- Country: Kazakhstan
- Summary: Purchase of Medicines (Hilak Forte, Theraflu Powder and Others), Amt: 128607.02
- KZT Ref No: 128175510
- Deadline: 17 Oct 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: KZT 128607.02
- Notice Type: Tender
- Document Ref. No.: 15540617-1
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lots: Bandage 7x14 not sterile | Sodium chloride, potassium chloride, sodium citrate, anhydrous glucose - Regidron powder | Aqueous substrate of metabolic products of Lactobacillus helveticus, Aqueous substrate of metabolic products of Escherichia coli, Aqueous substrate metabolic products of Lactobacillus acidophilus, Aqueous substrate of metabolic products of Enterococcus faecali - Hilak forte
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase of Medicines (Hilak Forte, Theraflu Powder and Others), Amt: 128607.02 - Kazakh Tender
The REPUBLICAN STATE INSTITUTION "AKTOBE LEGAL INSTITUTE OF THE MINISTRY OF INTERNAL AFFAIRS OF THE REPUBLIC OF KAZAKHSTAN NAMED AFTER MALKEJAR BUKENBAEV", a Government sector organization in Kazakhstan, has announced a new tender for Purchase of Medicines (Hilak Forte, Theraflu Powder and Others), Amt: 128607.02. This tender is published on KazakhTenders under KZT Ref No: 128175510 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-10-17.
The estimated tender value is KZT 128607.02, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
